[Brachytherapy in France in 2002: results of the ESTRO-PCBE questionnaire].
The authors report the results of the Patterns of Care for Brachytherapy in Europe (PCBE) throughout France. Responses were obtained for 91% of the Radiation Oncology departments, which have declared using brachytherapy for 67, and gave detailed data for 49 ones. The equipments and treated tumours were recorded. LDR brachytherapy remained the most often used (53.5%), followed by HDR (28%). PDR represented 5.5% and permanent implants 11%. The authors discuss the development of new equipment, with an aggregation of the structures, and an increase of the PDR and prostate implants use.
Peiffert
D
D
Département de radiothérapie, centre Alexis-Vautrin, 54511 Vandoeuvre-lès-Nancy cedex, France. d.peiffert@nancy.fnclcc.fr
Mazeron
J-J
JJ
Guedea
F
F
Nisin
R
R
D001918:Brachytherapy / Q000706:statistics & numerical data*; D002588:Cesium Radioisotopes / Q000627:therapeutic use; D005602:France; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D009369:Neoplasms / Q000532:radiotherapy; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires
D002588:Cesium Radioisotopes; D007457:Iodine Radioisotopes; D007496:Iridium Radioisotopes